Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.54 |
| ▸ | CASP3 | P42574 | 2/20 | 0.51 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.50 |
| ▸ | FABP7 | O15540 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | MDM4 | O15151 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28675945 | 0.89 | KMT2A (0.59) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL21332462 | 0.89 | KMT2A (0.66) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL120274 | 0.88 | KMT2A (0.61) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL17664939 | 0.87 | KMT2A (0.57) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL14123125 | 0.86 | KMT2A (0.53) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL8772818 | 0.85 | KMT2A (0.58) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL20825632 | 0.84 | KMT2A (0.54) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL27741275 | 0.84 | KMT2A (0.58) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL30845834 | 0.84 | KMT2A (0.60) | KMT2AEPHX2CASP3FABP5FABP7 | |
| SCHEMBL30845835 | 0.84 | KMT2A (0.60) | KMT2AEPHX2CASP3FABP5FABP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103613671-A | Al-18F mark fusion peptide and application thereof | FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY | 2014-03-05 | — | — | CN | claimed |
| CN-103848910-A | Solid synthetic method of semaglutide | SHENZHEN HYBIO PHARMACEUTICAL | 2014-06-11 | — | — | CN | disclosed |
| CN-103613671-A | Al-18F mark fusion peptide and application thereof | FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY | 2014-03-05 | — | — | CN | disclosed |
| CN-102918055-A | Novel glucagon analogues | NOVO NORDISK AS | 2013-02-06 | — | — | CN | disclosed |
| CN-102918056-A | Novel glucagon analogues | NOVO NORDISK AS | 2013-02-06 | — | — | CN | disclosed |